1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America ECMO Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America ECMO Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. North America ECMO Market Regional Analysis
6.1 North America ECMO Market Overview
6.2 North America ECMO Market Revenue 2020-2028 (US$ Million)
6.3 North America ECMO Market Forecast Analysis
7. North America ECMO Market Analysis – by Modality
7.1 Venoarterial ECMO
- 7.1.1 Overview
- 7.1.2 Venoarterial ECMO: North America ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Venovenous ECMO
- 7.2.1 Overview
- 7.2.2 Venovenous ECMO: North America ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Arteriovenous ECMO
- 7.3.1 Overview
- 7.3.2 Arteriovenous ECMO: North America ECMO Market – Revenue and Forecast to 2031 (US$ Million)
8. North America ECMO Market Analysis – by Application
8.1 Respiratory
- 8.1.1 Overview
- 8.1.2 Respiratory: North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cardiology
- 8.2.1 Overview
- 8.2.2 Cardiology: North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9. North America ECMO Market Analysis – by Age Group
9.1 Adults
- 9.1.1 Overview
- 9.1.2 Cardiology: North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Pediatrics
- 9.2.1 Overview
- 9.2.2 Cardiology: North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Neonates
- 9.3.1 Overview
- 9.3.2 Cardiology: North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
10. North America ECMO Market – North America Analysis
10.1 North America
- 10.1.1 North America ECMO Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 North America ECMO Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America ECMO Market Breakdown, by Modality
- 10.1.1.1.2 US: North America ECMO Market Breakdown, by Application
- 10.1.1.1.3 US: North America ECMO Market Breakdown, by Age Group
- 10.1.1.2 Canada:
North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America ECMO Market Breakdown, by Modality
- 10.1.1.2.2 Canada: North America ECMO Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America ECMO Market Breakdown, by Age Group
- 10.1.1.3 Mexico :
North America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America ECMO Market Breakdown, by Modality
- 10.1.1.3.2 Mexico : North America ECMO Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America ECMO Market Breakdown, by Age Group
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America ECMO Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 ABIOMED Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Braile Biomedica
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Eurosets S.R.L.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Fresenius Medical Care AG & Co KGaA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Getinge AB
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 LivaNova Plc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Medtronic Plc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 MicroPort Scientific Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Nipro Medical Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Terumo Group
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America ECMO Market
